Affinity Asset Advisors, LLC has filed its 13F form on May 14, 2025 for Q1 2025 where it was disclosed a total value porftolio of $896 Million distributed in 98 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Xenon Pharmaceuticals Inc. with a value of $44.6M, Verona Pharma PLC with a value of $39M, Arcellx, Inc. with a value of $34.8M, Alkermes Plc. with a value of $33M, and Nuvalent, Inc. with a value of $32.6M.
Examining the 13F form we can see an increase of $336M in the current position value, from $560M to 896M.
Affinity Asset Advisors, LLC is based out at New York, NY
Below you can find more details about Affinity Asset Advisors, LLC portfolio as well as his latest detailed transactions.
